Gamma delta T cells in cancer therapy: from tumor recognition to novel treatments
Frontiers in Medicine · 19.12.2024 · 11
DOI: 10.3389/fmed.2024.1480191 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Medicine, online erschienen am 19.12.2024. Verfasst von Xinyu Luo und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, China. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Traditional immunotherapies mainly focus on αβ T cell-based strategies, which depend on MHC-mediated antigen recognition. However, this approach poses significant challenges in treating recurrent tumors, as immune escape mechanisms are widespread. γδ T cells, with their ability for MHC-independent antigen presentation, offer a promising alternative that could potentially overcome limitations observed in traditional immunotherapies. These cells play a role in tumor immune surveillance through a unique mechanism of antigen recognition and synergistic interactions with other immune effector cells. In this review, we will discuss the biological properties of the Vδ1 and Vδ2 T subsets of γδ T cells, their immunomodulatory role within the tumor microenvironment, and the most recent clinical advances in γδ T cell-based related immunotherapies, including cell engaging strategies and adoptive cell therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, China.
- Computer Institute, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
- Transformation Research Lab, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
- The Third Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
Zitieren
APA
Luo, X., Lv, Y., Yang, J., Long, R., Qiu, J., Deng, Y., Tang, G., Zhang, C., Li, J., & Zuo, J. (2024). Gamma delta T cells in cancer therapy: from tumor recognition to novel treatments. Frontiers in Medicine, 11. https://doi.org/10.3389/fmed.2024.1480191
Vancouver
Luo X, Lv Y, Yang J, Long R, Qiu J, Deng Y, et al. Gamma delta T cells in cancer therapy: from tumor recognition to novel treatments. Frontiers in Medicine. 2024;11. doi:10.3389/fmed.2024.1480191
BibTeX
@article{Luo2024,
author = {Luo, Xinyu and Lv, Yufan and Yang, Jinsai and Long, Rou and Qiu, Jieya and Deng, Yuqi and Tang, Guiyang and Zhang, Chaohui and Li, Jiale and Zuo, Jianhong},
title = {Gamma delta T cells in cancer therapy: from tumor recognition to novel treatments},
journal = {Frontiers in Medicine},
year = {2024},
volume = {11},
doi = {10.3389/fmed.2024.1480191}
}
EUVIMED